Comparative and integrative functional genomics of HCC. (Q36519015)

14 August 2017

1 reference

title

Comparative and integrative functional genomics of HCC. (English)

1 reference

14 August 2017

1 reference

1 reference

Lee JS

1

1 reference

14 August 2017

Thorgeirsson SS

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

14 August 2017

1 reference

14 August 2017

25

1 reference

14 August 2017

27

1 reference

14 August 2017

3801-3809

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209561

14 August 2017

0 references

cites work

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

Identification of conserved regulatory elements by comparative genome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Gene-expression profiles predict survival of patients with lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Molecular classification of cutaneous malignant melanoma by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Focus on hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Genomic regulatory regions: insights from comparative sequence analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Computational genomics of noncoding RNA genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Hepatocellular carcinoma: recent trends in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Long Human–Mouse Sequence Alignments Reveal Novel Regulatory Elements: A Reason to Sequence the Mouse Genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarray

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Evolutionary Rate at the Molecular Level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Non-Darwinian Evolution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Application of comparative functional genomics to identify best-fit mouse models to study human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Comparative functional genomics for identifying models of human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Herceptin raises its sights beyond advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Mammalian phylogenomics comes of age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Comparative genomics: genome-wide analysis in metazoan eukaryotes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Prognostically useful gene-expression profiles in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Molecular genetics of small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209561

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209561

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference